Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation

被引:108
作者
Cameron, C. M.
Hu, Wei-Shou
Kaufman, Dan S.
机构
[1] Translat Res Facil, Stem Cell inst, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA
关键词
human embryonic stem cell; hematopoiesis; embryoid body; bioreactor;
D O I
10.1002/bit.20919
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
Human embryonic stem cells (hESCs) represent an important resource for novel cell-based regenerative medical therapies. hESCs are known to differentiate into mature cells of defined lineages through the formation of embryoid bodies (EBs) which are amenable to suspension culture for several weeks. However, EBs derived from hESCs in standard static cultures are typically non-homogeneous, leading to inefficient cellular development. Here, we systematically compare the formation, growth, and differentiation capabilities of hESC-derived EBs in stirred and static suspension cultures. A 15-fold expansion in total number of EB-derived cells cultured for 21 days in a stirred flask was observed, compared to a fourfold expansion in static (non-stirred) cultures. Additionally, stirred vessel mediated cultures have a more homogeneous EB morphology and size. Importantly, the EBs cultivated in spinner flasks retained comparable ability to produce hernatopoietic progenitor cells as those grown in static culture. These results demonstrate the decoupling between EB cultivation method and EB-derived cells' ability to form hematopoietic progenitors, and will allow for improved production of scalable quantities of hematopoietic cells or other differentiated cell lineages from hESCs in a controlled environment. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:938 / 948
页数:11
相关论文
共 52 条
[1]
Adelman CA, 2002, DEVELOPMENT, V129, P539
[2]
Regulation of hematopoietic stem cell growth [J].
Attar, EC ;
Scadden, DT .
LEUKEMIA, 2004, 18 (11) :1760-1768
[3]
Derivation of the hematopoietic stem cell compartment from human embryonic stem cell lines [J].
Bhatia, M .
HEMATOPOIETIC STEM CELLS V, 2005, 1044 :24-28
[4]
Hematopoietic stem cells:: from the bone to the bioreactor [J].
Cabrita, GJM ;
Ferreira, BS ;
da Silva, CL ;
Gonçalves, R ;
Almeida-Porada, G ;
Cabral, JMS .
TRENDS IN BIOTECHNOLOGY, 2003, 21 (05) :233-240
[5]
Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490
[6]
Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells [J].
Chadwick, K ;
Wang, LS ;
Li, L ;
Menendez, P ;
Murdoch, B ;
Rouleau, A ;
Bhatia, M .
BLOOD, 2003, 102 (03) :906-915
[7]
Choi K, 1998, DEVELOPMENT, V125, P725
[8]
Collins PC, 1998, BIOTECHNOL BIOENG, V59, P534, DOI 10.1002/(SICI)1097-0290(19980905)59:5<534::AID-BIT2>3.0.CO
[9]
2-B
[10]
Controlled, scalable embryonic stem cell differentiation culture [J].
Dang, SM ;
Gerecht-Nir, S ;
Chen, J ;
Itskovitz-Eldor, J ;
Zandstra, PW .
STEM CELLS, 2004, 22 (03) :275-282